文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Synthetic biology for combating leishmaniasis.

作者信息

Khandibharad Shweta, Singh Shailza

机构信息

Systems Medicine Laboratory, National Centre for Cell Science, Pune, India.

出版信息

Front Microbiol. 2024 Feb 1;15:1338749. doi: 10.3389/fmicb.2024.1338749. eCollection 2024.


DOI:10.3389/fmicb.2024.1338749
PMID:38362504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867266/
Abstract

Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus. Despite the efforts to control and treat the disease, it still remains a major public health problem in many countries. Synthetic biology is a rapidly evolving interdisciplinary field that combines biology, engineering, and computer science to design and construct novel biological systems. In recent years, synthetic biology approaches have shown great promise for developing new and effective strategies to combat leishmaniasis. In this perspective, we summarize the recent advances in the use of synthetic biology for the development of vaccines, diagnostic tools, and novel therapeutics for leishmaniasis.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10867266/745dd5b9b922/fmicb-15-1338749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10867266/0134784ce866/fmicb-15-1338749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10867266/745dd5b9b922/fmicb-15-1338749-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10867266/0134784ce866/fmicb-15-1338749-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dacb/10867266/745dd5b9b922/fmicb-15-1338749-g002.jpg

相似文献

[1]
Synthetic biology for combating leishmaniasis.

Front Microbiol. 2024-2-1

[2]
An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis.

Acta Trop. 2021-9

[3]
Leishmaniasis: prevention, parasite detection and treatment.

Curr Med Chem. 2012

[4]
Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets.

Life Sci. 2022-10-1

[5]
[Approaches and problems in vaccine development against leishmaniasis].

Turkiye Parazitol Derg. 2010

[6]
Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Front Immunol. 2014-5-23

[7]
Perspectives From Systems Biology to Improve Knowledge of Drug Resistance.

Front Cell Infect Microbiol. 2021

[8]
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection.

Expert Rev Vaccines. 2021-11

[9]
Developments in diagnosis and antileishmanial drugs.

Interdiscip Perspect Infect Dis. 2012

[10]
Recent Advances in Vaccines Against Leishmania Based on Patent Applications.

Recent Pat Biotechnol. 2018

引用本文的文献

[1]
Plant-derived products as anti-leishmanials which target mitochondria: a review.

Expert Rev Mol Med. 2025-3-26

[2]
Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis.

Pharmaceuticals (Basel). 2024-6-11

本文引用的文献

[1]
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis.

Front Med (Lausanne). 2023-5-17

[2]
Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine.

Front Mol Biosci. 2023-4-21

[3]
Malaria and leishmaniasis: Updates on co-infection.

Front Immunol. 2023

[4]
Drug resistance in Leishmania: does it really matter?

Trends Parasitol. 2023-4

[5]
Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.

Parasit Vectors. 2023-1-26

[6]
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.

Pharmaceutics. 2022-12-28

[7]
Novel CRISPR-based detection of species.

Front Microbiol. 2022-9-15

[8]
Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.

PLoS Negl Trop Dis. 2022-9

[9]
Mechanobiology of immune cells: Messengers, receivers and followers in leishmaniasis aiding synthetic devices.

Curr Res Immunol. 2022-8-23

[10]
as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model.

Front Immunol. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索